Global Autoimmune Drugs Market Size, Status and Forecast 2022
This report studies the global Autoimmune Drugs market, analyzes and researches the Autoimmune Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like
This report focuses on the top players in global market, like
- AbbVie
- Johnson & Johnson
- Biogen
- Amgen
- Pfizer
- F. Hoffmann-La Roche
- AstraZeneca
- GSK
- Merck
- Boehringer Ingelheim
- Novartis
- Sanofi
- Takeda Pharmaceuticals
- Eli Lilly
- Vertex Pharmaceuticals
- Eisai
- Antares Pharma
- UCB (Belgium)
- Acorda Therapeutics
- Lexicon Pharmaceuticals
- KaloBios Pharmaceuticals
- Can-Fite BioPharma
- Baxter
- Daiichi Sankyo
- Sandoz
- United States
- EU
- Japan
- China
- India
- Southeast Asia
- TNF Inhibitors
- IL Blockers
- COX Inhibitors
- Phosphodiesterase Type 4 Inhibitors
- Hospitals
- Clinics
- Other
Global Autoimmune Drugs Market Size, Status and Forecast 2022
1 INDUSTRY OVERVIEW OF AUTOIMMUNE DRUGS
1.1 Autoimmune Drugs Market Overview
1.1.1 Autoimmune Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Global Autoimmune Drugs Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Autoimmune Drugs Market by Type
1.3.1 TNF Inhibitors
1.3.2 IL Blockers
1.3.3 COX Inhibitors
1.3.4 Phosphodiesterase Type 4 Inhibitors
1.4 Autoimmune Drugs Market by End Users/Application
1.4.1 Hospitals
1.4.2 Clinics
1.4.3 Other
2 GLOBAL AUTOIMMUNE DRUGS COMPETITION ANALYSIS BY PLAYERS
2.1 Autoimmune Drugs Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 COMPANY (TOP PLAYERS) PROFILES
3.1 AbbVie
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Autoimmune Drugs Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Johnson & Johnson
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Autoimmune Drugs Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Biogen
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Autoimmune Drugs Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Amgen
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Autoimmune Drugs Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Pfizer
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Autoimmune Drugs Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 F. Hoffmann-La Roche
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Autoimmune Drugs Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 AstraZeneca
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Autoimmune Drugs Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 GSK
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Autoimmune Drugs Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Merck
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Autoimmune Drugs Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Boehringer Ingelheim
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Autoimmune Drugs Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Novartis
3.12 Sanofi
3.13 Takeda Pharmaceuticals
3.14 Eli Lilly
3.15 Vertex Pharmaceuticals
3.16 Eisai
3.17 Antares Pharma
3.18 UCB (Belgium)
3.19 Acorda Therapeutics
3.20 Lexicon Pharmaceuticals
3.21 KaloBios Pharmaceuticals
3.22 Can-Fite BioPharma
3.23 Baxter
3.24 Daiichi Sankyo
3.25 Sandoz
4 GLOBAL AUTOIMMUNE DRUGS MARKET SIZE BY TYPE AND APPLICATION (2012-2017)
4.1 Global Autoimmune Drugs Market Size by Type (2012-2017)
4.2 Global Autoimmune Drugs Market Size by Application (2012-2017)
4.3 Potential Application of Autoimmune Drugs in Future
4.4 Top Consumer/End Users of Autoimmune Drugs
5 UNITED STATES AUTOIMMUNE DRUGS DEVELOPMENT STATUS AND OUTLOOK
5.1 United States Autoimmune Drugs Market Size (2012-2017)
5.2 United States Autoimmune Drugs Market Size and Market Share by Players (2016 and 2017)
6 EU AUTOIMMUNE DRUGS DEVELOPMENT STATUS AND OUTLOOK
6.1 EU Autoimmune Drugs Market Size (2012-2017)
6.2 EU Autoimmune Drugs Market Size and Market Share by Players (2016 and 2017)
7 JAPAN AUTOIMMUNE DRUGS DEVELOPMENT STATUS AND OUTLOOK
7.1 Japan Autoimmune Drugs Market Size (2012-2017)
7.2 Japan Autoimmune Drugs Market Size and Market Share by Players (2016 and 2017)
8 CHINA AUTOIMMUNE DRUGS DEVELOPMENT STATUS AND OUTLOOK
8.1 China Autoimmune Drugs Market Size (2012-2017)
8.2 China Autoimmune Drugs Market Size and Market Share by Players (2016 and 2017)
9 INDIA AUTOIMMUNE DRUGS DEVELOPMENT STATUS AND OUTLOOK
9.1 India Autoimmune Drugs Market Size (2012-2017)
9.2 India Autoimmune Drugs Market Size and Market Share by Players (2016 and 2017)
10 SOUTHEAST ASIA AUTOIMMUNE DRUGS DEVELOPMENT STATUS AND OUTLOOK
10.1 Southeast Asia Autoimmune Drugs Market Size (2012-2017)
10.2 Southeast Asia Autoimmune Drugs Market Size and Market Share by Players (2016 and 2017)
11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)
11.1 Global Autoimmune Drugs Market Size (Value) by Regions (2017-2022)
11.1.1 United States Autoimmune Drugs Revenue and Growth Rate (2017-2022)
11.1.2 EU Autoimmune Drugs Revenue and Growth Rate (2017-2022)
11.1.3 Japan Autoimmune Drugs Revenue and Growth Rate (2017-2022)
11.1.4 China Autoimmune Drugs Revenue and Growth Rate (2017-2022)
11.1.5 India Autoimmune Drugs Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Autoimmune Drugs Revenue and Growth Rate (2017-2022)
11.2 Global Autoimmune Drugs Market Size (Value) by Type (2017-2022)
11.3 Global Autoimmune Drugs Market Size by Application (2017-2022)
12 AUTOIMMUNE DRUGS MARKET DYNAMICS
12.1 Autoimmune Drugs Market Opportunities
12.2 Autoimmune Drugs Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Autoimmune Drugs Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Autoimmune Drugs Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 MARKET EFFECT FACTORS ANALYSIS
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 RESEARCH FINDING/CONCLUSION
15 APPENDIX
Methodology
Analyst Introduction
Data Source
The report requires updating with new data and is sent in 2-3 business days after order is placed.
1 INDUSTRY OVERVIEW OF AUTOIMMUNE DRUGS
1.1 Autoimmune Drugs Market Overview
1.1.1 Autoimmune Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Global Autoimmune Drugs Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Autoimmune Drugs Market by Type
1.3.1 TNF Inhibitors
1.3.2 IL Blockers
1.3.3 COX Inhibitors
1.3.4 Phosphodiesterase Type 4 Inhibitors
1.4 Autoimmune Drugs Market by End Users/Application
1.4.1 Hospitals
1.4.2 Clinics
1.4.3 Other
2 GLOBAL AUTOIMMUNE DRUGS COMPETITION ANALYSIS BY PLAYERS
2.1 Autoimmune Drugs Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 COMPANY (TOP PLAYERS) PROFILES
3.1 AbbVie
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Autoimmune Drugs Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Johnson & Johnson
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Autoimmune Drugs Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Biogen
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Autoimmune Drugs Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Amgen
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Autoimmune Drugs Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Pfizer
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Autoimmune Drugs Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 F. Hoffmann-La Roche
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Autoimmune Drugs Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 AstraZeneca
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Autoimmune Drugs Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 GSK
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Autoimmune Drugs Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Merck
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Autoimmune Drugs Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Boehringer Ingelheim
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Autoimmune Drugs Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Novartis
3.12 Sanofi
3.13 Takeda Pharmaceuticals
3.14 Eli Lilly
3.15 Vertex Pharmaceuticals
3.16 Eisai
3.17 Antares Pharma
3.18 UCB (Belgium)
3.19 Acorda Therapeutics
3.20 Lexicon Pharmaceuticals
3.21 KaloBios Pharmaceuticals
3.22 Can-Fite BioPharma
3.23 Baxter
3.24 Daiichi Sankyo
3.25 Sandoz
4 GLOBAL AUTOIMMUNE DRUGS MARKET SIZE BY TYPE AND APPLICATION (2012-2017)
4.1 Global Autoimmune Drugs Market Size by Type (2012-2017)
4.2 Global Autoimmune Drugs Market Size by Application (2012-2017)
4.3 Potential Application of Autoimmune Drugs in Future
4.4 Top Consumer/End Users of Autoimmune Drugs
5 UNITED STATES AUTOIMMUNE DRUGS DEVELOPMENT STATUS AND OUTLOOK
5.1 United States Autoimmune Drugs Market Size (2012-2017)
5.2 United States Autoimmune Drugs Market Size and Market Share by Players (2016 and 2017)
6 EU AUTOIMMUNE DRUGS DEVELOPMENT STATUS AND OUTLOOK
6.1 EU Autoimmune Drugs Market Size (2012-2017)
6.2 EU Autoimmune Drugs Market Size and Market Share by Players (2016 and 2017)
7 JAPAN AUTOIMMUNE DRUGS DEVELOPMENT STATUS AND OUTLOOK
7.1 Japan Autoimmune Drugs Market Size (2012-2017)
7.2 Japan Autoimmune Drugs Market Size and Market Share by Players (2016 and 2017)
8 CHINA AUTOIMMUNE DRUGS DEVELOPMENT STATUS AND OUTLOOK
8.1 China Autoimmune Drugs Market Size (2012-2017)
8.2 China Autoimmune Drugs Market Size and Market Share by Players (2016 and 2017)
9 INDIA AUTOIMMUNE DRUGS DEVELOPMENT STATUS AND OUTLOOK
9.1 India Autoimmune Drugs Market Size (2012-2017)
9.2 India Autoimmune Drugs Market Size and Market Share by Players (2016 and 2017)
10 SOUTHEAST ASIA AUTOIMMUNE DRUGS DEVELOPMENT STATUS AND OUTLOOK
10.1 Southeast Asia Autoimmune Drugs Market Size (2012-2017)
10.2 Southeast Asia Autoimmune Drugs Market Size and Market Share by Players (2016 and 2017)
11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)
11.1 Global Autoimmune Drugs Market Size (Value) by Regions (2017-2022)
11.1.1 United States Autoimmune Drugs Revenue and Growth Rate (2017-2022)
11.1.2 EU Autoimmune Drugs Revenue and Growth Rate (2017-2022)
11.1.3 Japan Autoimmune Drugs Revenue and Growth Rate (2017-2022)
11.1.4 China Autoimmune Drugs Revenue and Growth Rate (2017-2022)
11.1.5 India Autoimmune Drugs Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Autoimmune Drugs Revenue and Growth Rate (2017-2022)
11.2 Global Autoimmune Drugs Market Size (Value) by Type (2017-2022)
11.3 Global Autoimmune Drugs Market Size by Application (2017-2022)
12 AUTOIMMUNE DRUGS MARKET DYNAMICS
12.1 Autoimmune Drugs Market Opportunities
12.2 Autoimmune Drugs Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Autoimmune Drugs Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Autoimmune Drugs Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 MARKET EFFECT FACTORS ANALYSIS
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 RESEARCH FINDING/CONCLUSION
15 APPENDIX
Methodology
Analyst Introduction
Data Source
The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES
Figure Autoimmune Drugs Product Scope
Figure Global Autoimmune Drugs Market Size (Million USD) (2012-2017)
Table Global Autoimmune Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Autoimmune Drugs Market Share by Regions in 2016
Figure United States Autoimmune Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Autoimmune Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Autoimmune Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Autoimmune Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Autoimmune Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Autoimmune Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Autoimmune Drugs Market Share by Type in 2016
Figure TNF Inhibitors Market Size (Million USD) and Growth Rate (2012-2017)
Figure IL Blockers Market Size (Million USD) and Growth Rate (2012-2017)
Figure COX Inhibitors Market Size (Million USD) and Growth Rate (2012-2017)
Figure Phosphodiesterase Type 4 Inhibitors Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Autoimmune Drugs Market Share by Application in 2016
Table Key Downstream Customer in Hospitals
Figure Autoimmune Drugs Market Size (Million USD) and Growth Rate in Hospitals (2012-2017)
Table Key Downstream Customer in Clinics
Figure Autoimmune Drugs Market Size (Million USD) and Growth Rate in Clinics (2012-2017)
Table Key Downstream Customer in Other
Figure Autoimmune Drugs Market Size (Million USD) and Growth Rate in Other (2012-2017)
Table Autoimmune Drugs Market Size (Million USD) by Players (2016 and 2017)
Figure Autoimmune Drugs Market Size Share by Players in 2016
Figure Autoimmune Drugs Market Size Share by Players in 2017
Table AbbVie Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of AbbVie (2012-2017)
Figure AbbVie Autoimmune Drugs Business Revenue Market Share in 2016
Table Johnson & Johnson Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Johnson & Johnson (2012-2017)
Figure Johnson & Johnson Autoimmune Drugs Business Revenue Market Share in 2016
Table Biogen Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Biogen (2012-2017)
Figure Biogen Autoimmune Drugs Business Revenue Market Share in 2016
Table Amgen Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Amgen (2012-2017)
Figure Amgen Autoimmune Drugs Business Revenue Market Share in 2016
Table Pfizer Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Pfizer (2012-2017)
Figure Pfizer Autoimmune Drugs Business Revenue Market Share in 2016
Table F. Hoffmann-La Roche Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of F. Hoffmann-La Roche (2012-2017)
Figure F. Hoffmann-La Roche Autoimmune Drugs Business Revenue Market Share in 2016
Table AstraZeneca Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of AstraZeneca (2012-2017)
Figure AstraZeneca Autoimmune Drugs Business Revenue Market Share in 2016
Table GSK Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of GSK (2012-2017)
Figure GSK Autoimmune Drugs Business Revenue Market Share in 2016
Table Merck Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Merck (2012-2017)
Figure Merck Autoimmune Drugs Business Revenue Market Share in 2016
Table Boehringer Ingelheim Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Boehringer Ingelheim (2012-2017)
Figure Boehringer Ingelheim Autoimmune Drugs Business Revenue Market Share in 2016
Table Novartis Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Novartis (2012-2017)
Figure Novartis Autoimmune Drugs Business Revenue Market Share in 2016
Table Sanofi Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Sanofi (2012-2017)
Figure Sanofi Autoimmune Drugs Business Revenue Market Share in 2016
Table Takeda Pharmaceuticals Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Takeda Pharmaceuticals (2012-2017)
Figure Takeda Pharmaceuticals Autoimmune Drugs Business Revenue Market Share in 2016
Table Eli Lilly Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Eli Lilly (2012-2017)
Figure Eli Lilly Autoimmune Drugs Business Revenue Market Share in 2016
Table Vertex Pharmaceuticals Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Vertex Pharmaceuticals (2012-2017)
Figure Vertex Pharmaceuticals Autoimmune Drugs Business Revenue Market Share in 2016
Table Eisai Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Eisai (2012-2017)
Figure Eisai Autoimmune Drugs Business Revenue Market Share in 2016
Table Antares Pharma Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Antares Pharma (2012-2017)
Figure Antares Pharma Autoimmune Drugs Business Revenue Market Share in 2016
Table UCB (Belgium) Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of UCB (Belgium) (2012-2017)
Figure UCB (Belgium) Autoimmune Drugs Business Revenue Market Share in 2016
Table Acorda Therapeutics Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Acorda Therapeutics (2012-2017)
Figure Acorda Therapeutics Autoimmune Drugs Business Revenue Market Share in 2016
Table Lexicon Pharmaceuticals Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Lexicon Pharmaceuticals (2012-2017)
Figure Lexicon Pharmaceuticals Autoimmune Drugs Business Revenue Market Share in 2016
Table KaloBios Pharmaceuticals Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of KaloBios Pharmaceuticals (2012-2017)
Figure KaloBios Pharmaceuticals Autoimmune Drugs Business Revenue Market Share in 2016
Table Can-Fite BioPharma Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Can-Fite BioPharma (2012-2017)
Figure Can-Fite BioPharma Autoimmune Drugs Business Revenue Market Share in 2016
Table Baxter Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Baxter (2012-2017)
Figure Baxter Autoimmune Drugs Business Revenue Market Share in 2016
Table Daiichi Sankyo Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Daiichi Sankyo (2012-2017)
Figure Daiichi Sankyo Autoimmune Drugs Business Revenue Market Share in 2016
Table Sandoz Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Sandoz (2012-2017)
Figure Sandoz Autoimmune Drugs Business Revenue Market Share in 2016
Table Global Autoimmune Drugs Market Size (Million USD) by Type (2012-2017)
Figure Global Autoimmune Drugs Market Size Share by Type in 2012
Figure Global Autoimmune Drugs Market Size Share by Type in 2013
Figure Global Autoimmune Drugs Market Size Share by Type in 2014
Figure Global Autoimmune Drugs Market Size Share by Type in 2015
Figure Global Autoimmune Drugs Market Size Share by Type in 2016
Figure Global Autoimmune Drugs Market Size Share by Type in 2017
Table Global Autoimmune Drugs Market Size (Million USD) by Application (2012-2017)
Figure Global Autoimmune Drugs Market Size (Million USD) by Application in 2012
Figure Global Autoimmune Drugs Market Size (Million USD) by Application in 2013
Figure Global Autoimmune Drugs Market Size (Million USD) by Application in 2014
Figure Global Autoimmune Drugs Market Size (Million USD) by Application in 2015
Figure Global Autoimmune Drugs Market Size (Million USD) by Application in 2016
Figure Global Autoimmune Drugs Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Autoimmune Drugs
Figure United States Autoimmune Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Autoimmune Drugs Market Size (Million USD) by Players (2012-2017)
Figure United States Autoimmune Drugs Market Size Share by Players in 2016
Figure United States Autoimmune Drugs Market Size Share by Players in 2017
Figure EU Autoimmune Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Autoimmune Drugs Market Size (Million USD) by Players (2012-2017)
Figure EU Autoimmune Drugs Market Size Share by Players in 2016
Figure EU Autoimmune Drugs Market Size Share by Players in 2017
Figure Japan Autoimmune Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Autoimmune Drugs Market Size (Million USD) by Players (2012-2017)
Figure Japan Autoimmune Drugs Market Size Share by Players in 2016
Figure Japan Autoimmune Drugs Market Size Share by Players in 2017
Figure China Autoimmune Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Autoimmune Drugs Market Size (Million USD) by Players (2012-2017)
Figure China Autoimmune Drugs Market Size Share by Players in 2016
Figure China Autoimmune Drugs Market Size Share by Players in 2017
Figure India Autoimmune Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Autoimmune Drugs Market Size (Million USD) by Players (2012-2017)
Figure India Autoimmune Drugs Market Size Share by Players in 2016
Figure India Autoimmune Drugs Market Size Share by Players in 2017
Figure Southeast Asia Autoimmune Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Autoimmune Drugs Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Autoimmune Drugs Market Size Share by Players in 2016
Figure Southeast Asia Autoimmune Drugs Market Size Share by Players in 2017
Figure Global Autoimmune Drugs Market Size (Million USD) by Regions (2017-2022)
Table Global Autoimmune Drugs Market Size (Million USD) by Regions (2017-2022)
Figure Global Autoimmune Drugs Market Size Share by Regions in 2017
Figure Global Autoimmune Drugs Market Size Share by Regions in 2022
Figure United States Autoimmune Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Autoimmune Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Autoimmune Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Autoimmune Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Autoimmune Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Autoimmune Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Autoimmune Drugs Market Size (Million USD) by Type (2017-2022)
Figure Global Autoimmune Drugs Market Size Share by Type in 2017
Figure Global Autoimmune Drugs Market Size Share by Type in 2022
Table Global Autoimmune Drugs Market Size (Million USD) by Application (2017-2022)
Figure Global Autoimmune Drugs Market Size (Million USD) by Application in 2017
Figure Global Autoimmune Drugs Market Size (Million USD) by Application in 2022
Figure Autoimmune Drugs Product Scope
Figure Global Autoimmune Drugs Market Size (Million USD) (2012-2017)
Table Global Autoimmune Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Autoimmune Drugs Market Share by Regions in 2016
Figure United States Autoimmune Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Autoimmune Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Autoimmune Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Autoimmune Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Autoimmune Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Autoimmune Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Autoimmune Drugs Market Share by Type in 2016
Figure TNF Inhibitors Market Size (Million USD) and Growth Rate (2012-2017)
Figure IL Blockers Market Size (Million USD) and Growth Rate (2012-2017)
Figure COX Inhibitors Market Size (Million USD) and Growth Rate (2012-2017)
Figure Phosphodiesterase Type 4 Inhibitors Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Autoimmune Drugs Market Share by Application in 2016
Table Key Downstream Customer in Hospitals
Figure Autoimmune Drugs Market Size (Million USD) and Growth Rate in Hospitals (2012-2017)
Table Key Downstream Customer in Clinics
Figure Autoimmune Drugs Market Size (Million USD) and Growth Rate in Clinics (2012-2017)
Table Key Downstream Customer in Other
Figure Autoimmune Drugs Market Size (Million USD) and Growth Rate in Other (2012-2017)
Table Autoimmune Drugs Market Size (Million USD) by Players (2016 and 2017)
Figure Autoimmune Drugs Market Size Share by Players in 2016
Figure Autoimmune Drugs Market Size Share by Players in 2017
Table AbbVie Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of AbbVie (2012-2017)
Figure AbbVie Autoimmune Drugs Business Revenue Market Share in 2016
Table Johnson & Johnson Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Johnson & Johnson (2012-2017)
Figure Johnson & Johnson Autoimmune Drugs Business Revenue Market Share in 2016
Table Biogen Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Biogen (2012-2017)
Figure Biogen Autoimmune Drugs Business Revenue Market Share in 2016
Table Amgen Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Amgen (2012-2017)
Figure Amgen Autoimmune Drugs Business Revenue Market Share in 2016
Table Pfizer Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Pfizer (2012-2017)
Figure Pfizer Autoimmune Drugs Business Revenue Market Share in 2016
Table F. Hoffmann-La Roche Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of F. Hoffmann-La Roche (2012-2017)
Figure F. Hoffmann-La Roche Autoimmune Drugs Business Revenue Market Share in 2016
Table AstraZeneca Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of AstraZeneca (2012-2017)
Figure AstraZeneca Autoimmune Drugs Business Revenue Market Share in 2016
Table GSK Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of GSK (2012-2017)
Figure GSK Autoimmune Drugs Business Revenue Market Share in 2016
Table Merck Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Merck (2012-2017)
Figure Merck Autoimmune Drugs Business Revenue Market Share in 2016
Table Boehringer Ingelheim Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Boehringer Ingelheim (2012-2017)
Figure Boehringer Ingelheim Autoimmune Drugs Business Revenue Market Share in 2016
Table Novartis Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Novartis (2012-2017)
Figure Novartis Autoimmune Drugs Business Revenue Market Share in 2016
Table Sanofi Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Sanofi (2012-2017)
Figure Sanofi Autoimmune Drugs Business Revenue Market Share in 2016
Table Takeda Pharmaceuticals Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Takeda Pharmaceuticals (2012-2017)
Figure Takeda Pharmaceuticals Autoimmune Drugs Business Revenue Market Share in 2016
Table Eli Lilly Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Eli Lilly (2012-2017)
Figure Eli Lilly Autoimmune Drugs Business Revenue Market Share in 2016
Table Vertex Pharmaceuticals Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Vertex Pharmaceuticals (2012-2017)
Figure Vertex Pharmaceuticals Autoimmune Drugs Business Revenue Market Share in 2016
Table Eisai Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Eisai (2012-2017)
Figure Eisai Autoimmune Drugs Business Revenue Market Share in 2016
Table Antares Pharma Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Antares Pharma (2012-2017)
Figure Antares Pharma Autoimmune Drugs Business Revenue Market Share in 2016
Table UCB (Belgium) Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of UCB (Belgium) (2012-2017)
Figure UCB (Belgium) Autoimmune Drugs Business Revenue Market Share in 2016
Table Acorda Therapeutics Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Acorda Therapeutics (2012-2017)
Figure Acorda Therapeutics Autoimmune Drugs Business Revenue Market Share in 2016
Table Lexicon Pharmaceuticals Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Lexicon Pharmaceuticals (2012-2017)
Figure Lexicon Pharmaceuticals Autoimmune Drugs Business Revenue Market Share in 2016
Table KaloBios Pharmaceuticals Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of KaloBios Pharmaceuticals (2012-2017)
Figure KaloBios Pharmaceuticals Autoimmune Drugs Business Revenue Market Share in 2016
Table Can-Fite BioPharma Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Can-Fite BioPharma (2012-2017)
Figure Can-Fite BioPharma Autoimmune Drugs Business Revenue Market Share in 2016
Table Baxter Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Baxter (2012-2017)
Figure Baxter Autoimmune Drugs Business Revenue Market Share in 2016
Table Daiichi Sankyo Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Daiichi Sankyo (2012-2017)
Figure Daiichi Sankyo Autoimmune Drugs Business Revenue Market Share in 2016
Table Sandoz Basic Information List
Table Autoimmune Drugs Business Revenue (Million USD) of Sandoz (2012-2017)
Figure Sandoz Autoimmune Drugs Business Revenue Market Share in 2016
Table Global Autoimmune Drugs Market Size (Million USD) by Type (2012-2017)
Figure Global Autoimmune Drugs Market Size Share by Type in 2012
Figure Global Autoimmune Drugs Market Size Share by Type in 2013
Figure Global Autoimmune Drugs Market Size Share by Type in 2014
Figure Global Autoimmune Drugs Market Size Share by Type in 2015
Figure Global Autoimmune Drugs Market Size Share by Type in 2016
Figure Global Autoimmune Drugs Market Size Share by Type in 2017
Table Global Autoimmune Drugs Market Size (Million USD) by Application (2012-2017)
Figure Global Autoimmune Drugs Market Size (Million USD) by Application in 2012
Figure Global Autoimmune Drugs Market Size (Million USD) by Application in 2013
Figure Global Autoimmune Drugs Market Size (Million USD) by Application in 2014
Figure Global Autoimmune Drugs Market Size (Million USD) by Application in 2015
Figure Global Autoimmune Drugs Market Size (Million USD) by Application in 2016
Figure Global Autoimmune Drugs Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Autoimmune Drugs
Figure United States Autoimmune Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Autoimmune Drugs Market Size (Million USD) by Players (2012-2017)
Figure United States Autoimmune Drugs Market Size Share by Players in 2016
Figure United States Autoimmune Drugs Market Size Share by Players in 2017
Figure EU Autoimmune Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Autoimmune Drugs Market Size (Million USD) by Players (2012-2017)
Figure EU Autoimmune Drugs Market Size Share by Players in 2016
Figure EU Autoimmune Drugs Market Size Share by Players in 2017
Figure Japan Autoimmune Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Autoimmune Drugs Market Size (Million USD) by Players (2012-2017)
Figure Japan Autoimmune Drugs Market Size Share by Players in 2016
Figure Japan Autoimmune Drugs Market Size Share by Players in 2017
Figure China Autoimmune Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Autoimmune Drugs Market Size (Million USD) by Players (2012-2017)
Figure China Autoimmune Drugs Market Size Share by Players in 2016
Figure China Autoimmune Drugs Market Size Share by Players in 2017
Figure India Autoimmune Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Autoimmune Drugs Market Size (Million USD) by Players (2012-2017)
Figure India Autoimmune Drugs Market Size Share by Players in 2016
Figure India Autoimmune Drugs Market Size Share by Players in 2017
Figure Southeast Asia Autoimmune Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Autoimmune Drugs Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Autoimmune Drugs Market Size Share by Players in 2016
Figure Southeast Asia Autoimmune Drugs Market Size Share by Players in 2017
Figure Global Autoimmune Drugs Market Size (Million USD) by Regions (2017-2022)
Table Global Autoimmune Drugs Market Size (Million USD) by Regions (2017-2022)
Figure Global Autoimmune Drugs Market Size Share by Regions in 2017
Figure Global Autoimmune Drugs Market Size Share by Regions in 2022
Figure United States Autoimmune Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Autoimmune Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Autoimmune Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Autoimmune Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Autoimmune Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Autoimmune Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Autoimmune Drugs Market Size (Million USD) by Type (2017-2022)
Figure Global Autoimmune Drugs Market Size Share by Type in 2017
Figure Global Autoimmune Drugs Market Size Share by Type in 2022
Table Global Autoimmune Drugs Market Size (Million USD) by Application (2017-2022)
Figure Global Autoimmune Drugs Market Size (Million USD) by Application in 2017
Figure Global Autoimmune Drugs Market Size (Million USD) by Application in 2022
